115 related articles for article (PubMed ID: 22083716)
1. Fusion of HSA influences TNF-α neutralizing activity of shTNFRs.
Zhan J; Chen Y; Yuan HY; Li H; Lu H
Biotechnol Lett; 2012 Mar; 34(3):417-23. PubMed ID: 22083716
[TBL] [Abstract][Full Text] [Related]
2. Generation of soluble human tumor necrosis factor-α receptor 1-Fc transgenic pig.
Cho B; Koo OJ; Hwang JI; Kim H; Lee EM; Hurh S; Park SJ; Ro H; Yang J; Surh CD; D'Apice AJ; Lee BC; Ahn C
Transplantation; 2011 Jul; 92(2):139-47. PubMed ID: 21694665
[TBL] [Abstract][Full Text] [Related]
3. Superior serum half life of albumin tagged TNF ligands.
Müller N; Schneider B; Pfizenmaier K; Wajant H
Biochem Biophys Res Commun; 2010 Jun; 396(4):793-9. PubMed ID: 20447380
[TBL] [Abstract][Full Text] [Related]
4. A novel human scFv fragment against TNF-alpha from de novo design method.
Chang H; Qin W; Li Y; Zhang J; Lin Z; Lv M; Sun Y; Feng J; Shen B
Mol Immunol; 2007 Jul; 44(15):3789-96. PubMed ID: 17485112
[TBL] [Abstract][Full Text] [Related]
5. [Purification and activity assay of HSA-AX15 (R13K) fusion protein expressed in Pichia pastoris].
Zhao HL; Xue C; Xiong XH; Zhang W; Yang BF; Liu ZM
Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):254-8. PubMed ID: 16013485
[TBL] [Abstract][Full Text] [Related]
6. An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action.
Berger V; Richter F; Zettlitz K; Unverdorben F; Scheurich P; Herrmann A; Pfizenmaier K; Kontermann RE
Protein Eng Des Sel; 2013 Oct; 26(10):581-7. PubMed ID: 24006371
[TBL] [Abstract][Full Text] [Related]
7. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides.
Qin W; Feng J; Li Y; Lin Z; Shen B
Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837
[TBL] [Abstract][Full Text] [Related]
8. Expression, purification and characterization of recombinant human interleukin-2-serum albumin (rhIL-2-HSA) fusion protein in Pichia pastoris.
Lei J; Guan B; Li B; Duan Z; Chen Y; Li H; Jin J
Protein Expr Purif; 2012 Jul; 84(1):154-60. PubMed ID: 22609631
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification, and characterization of recombinant human serum albumin fusion protein with two human glucagon-like peptide-1 mutants in Pichia pastoris.
Dou WF; Lei JY; Zhang LF; Xu ZH; Chen Y; Jin J
Protein Expr Purif; 2008 Sep; 61(1):45-9. PubMed ID: 18556214
[TBL] [Abstract][Full Text] [Related]
10. Fine tuning of receptor-selectivity for tumor necrosis factor-α using a phage display system with one-step competitive panning.
Abe Y; Yoshikawa T; Inoue M; Nomura T; Furuya T; Yamashita T; Nagano K; Nabeshi H; Yoshioka Y; Mukai Y; Nakagawa S; Kamada H; Tsutsumi Y; Tsunoda S
Biomaterials; 2011 Aug; 32(23):5498-504. PubMed ID: 21546081
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of a novel exendin-4 human serum albumin fusion protein expressed in Pichia pastoris.
Huang YS; Chen Z; Chen YQ; Ma GC; Shan JF; Liu W; Zhou LF
J Pept Sci; 2008 May; 14(5):588-95. PubMed ID: 17994612
[TBL] [Abstract][Full Text] [Related]
12. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action.
Kontermann RE; Münkel S; Neumeyer J; Müller D; Branschädel M; Scheurich P; Pfizenmaier K
J Immunother; 2008 Apr; 31(3):225-34. PubMed ID: 18317365
[TBL] [Abstract][Full Text] [Related]
13. The effect of albumin fusion patterns on the production and bioactivity of the somatostatin-14 fusion protein in Pichia pastoris.
Ding Y; Fan J; Li W; Yang R; Peng Y; Deng L; Wu Y; Fu Q
Appl Biochem Biotechnol; 2013 Aug; 170(7):1637-48. PubMed ID: 23712794
[TBL] [Abstract][Full Text] [Related]
14. A long-acting tumor necrosis factor alpha-binding protein demonstrates activity in both in vitro and in vivo models of endometriosis.
Altan ZM; Denis D; Kagan D; Grund EM; Palmer SS; Nataraja SG
J Pharmacol Exp Ther; 2010 Aug; 334(2):460-6. PubMed ID: 20435921
[TBL] [Abstract][Full Text] [Related]
15. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
[TBL] [Abstract][Full Text] [Related]
16. The effect of gene copy number and co-expression of chaperone on production of albumin fusion proteins in Pichia pastoris.
Shen Q; Wu M; Wang HB; Naranmandura H; Chen SQ
Appl Microbiol Biotechnol; 2012 Nov; 96(3):763-72. PubMed ID: 22885695
[TBL] [Abstract][Full Text] [Related]
17. Simple and highly sensitive assay system for TNFR2-mediated soluble- and transmembrane-TNF activity.
Abe Y; Yoshikawa T; Kamada H; Shibata H; Nomura T; Minowa K; Kayamuro H; Katayama K; Miyoshi H; Mukai Y; Yoshioka Y; Nakagawa S; Tsunoda S; Tsutsumi Y
J Immunol Methods; 2008 Jun; 335(1-2):71-8. PubMed ID: 18417150
[TBL] [Abstract][Full Text] [Related]
18. Localization of gene and protein expressions of tumor necrosis factor-{alpha} and tumor necrosis factor receptor types I and II in the bovine corpus luteum during the estrous cycle.
Sakumoto R; Vermehren M; Kenngott RA; Okuda K; Sinowatz F
J Anim Sci; 2011 Oct; 89(10):3040-7. PubMed ID: 21551345
[TBL] [Abstract][Full Text] [Related]
19. [Eukaryotic expression and bioactivity determination of the fusion protein sTNFRII-gAD consisting of soluble tumor necrosis factor receptor II and globular domain of adiponectin].
Chen S; He Q; Dong X; Wu X; Gao J
Sheng Wu Gong Cheng Xue Bao; 2010 Feb; 26(2):207-15. PubMed ID: 20432940
[TBL] [Abstract][Full Text] [Related]
20. The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein.
Lee JH; Cho JH; Yeo J; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
Biologicals; 2013 Mar; 41(2):77-83. PubMed ID: 23190454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
